🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein

Viruses(2025)10.3390/v17081095Source: DataRank Database

Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein is a research paper published in Viruses (2025). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 7.36)OA: goldTopics (55)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Jonna B. Westover ORCID,Kendall A. Lundgreen ORCID,Philip Hicks ORCID,Raegan J. Petch ORCID,Jordan T. Ort ORCID

Live enrichment

PubMed:40872809 OpenAlex:https://openalex.org/W4413137280

National Institute of Allergy and Infectious Diseases

Grant: R21AI142638

National Institute of Allergy and Infectious Diseases

Grant: R01AI152236

National Institute of Allergy and Infectious Diseases

Grant: T32AI007324

National Institute of Allergy and Infectious Diseases

Grant: T32AI055400

National Institute of Allergy and Infectious Diseases

Grant: R01-AI146101-01

National Institute of Allergy and Infectious Diseases

Grant: R01-AI153064-01

NIH HHS

Grant: R01AI146101-01

NIAID NIH HHS

Grant: T32 AI070077

NIAID NIH HHS

Grant: R01 AI146101

NIAID NIH HHS

Grant: R01 AI153064

NIH HHS

Grant: R01AI153064-01

FWCI

7.36

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4915/17/8/1095/pdf?version=1754649605

publisherhttps://www.mdpi.com/1999-4915/17/8/1095/pdf?version=1754649605

publisherhttps://www.mdpi.com/1999-4915/17/8/1095/pdf

journalhttps://doi.org/10.3390/v17081095

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40872809

Fields of Study

Viral Infections and VectorsMosquito-borne diseases and controlVector-Borne Animal DiseasesAnimalsMiceViral VaccinesAntibodies, ViralRNA, MessengerPhlebovirusVaccinationFemaleGlycoproteinsVaccines, SyntheticSevere Fever with Thrombocytopenia SyndromeImmunity, CellularMice, Inbred BALB CAntibodies, NeutralizingImmunoglobulin GmRNA VaccinesNanoparticles

MeSH Terms

Severe Fever with Thrombocytopenia SyndromemRNA VaccinesAnimalsAntibodies, ViralFemaleGlycoproteinsImmunoglobulin GImmunity, CellularMice, Inbred BALB CRNA, MessengerVaccinationVaccines, SyntheticViral VaccinesPhlebovirusMiceNanoparticlesAntibodies, Neutralizing

Keywords

ImmunogenicityVirologyHeterologousBiologyImmunizationVaccinationImmune systemImmunityAntibodyImmunologyGeneGeneticsDabie bandavirusmRNArVSVsevere fever with thrombocytopenia syndrome virusvaccinevesicular stomatitis virus

Sustainable Development Goals

SDG 0: Good health and well-being